KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Equity Average (2016 - 2025)

Historic Equity Average for Medtronic (MDT) over the last 11 years, with Q4 2025 value amounting to $48.5 billion.

  • Medtronic's Equity Average rose 11.77% to $48.5 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $48.5 billion, marking a year-over-year increase of 11.77%. This contributed to the annual value of $49.3 billion for FY2025, which is 333.94% down from last year.
  • As of Q4 2025, Medtronic's Equity Average stood at $48.5 billion, which was up 11.77% from $48.2 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's Equity Average registered a high of $52.8 billion during Q3 2022, and its lowest value of $48.2 billion during Q3 2025.
  • In the last 5 years, Medtronic's Equity Average had a median value of $51.5 billion in 2023 and averaged $50.9 billion.
  • In the last 5 years, Medtronic's Equity Average soared by 358.34% in 2022 and then plummeted by 595.75% in 2024.
  • Medtronic's Equity Average (Quarter) stood at $51.9 billion in 2021, then increased by 1.04% to $52.4 billion in 2022, then dropped by 1.8% to $51.5 billion in 2023, then fell by 5.96% to $48.4 billion in 2024, then rose by 0.12% to $48.5 billion in 2025.
  • Its Equity Average was $48.5 billion in Q4 2025, compared to $48.2 billion in Q3 2025 and $48.9 billion in Q2 2025.